Market Overview:
The global prostacyclin (PGI2) ELISA kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cardiovascular diseases, rising geriatric population, and technological advancements in prostacyclin (PGI2) ELISA kits. Based on type, the global prostacyclin (PGI2) ELISA kits market can be segmented into serum, plasma, and other biological fluids. The serum segment is expected to account for the largest share of the global prostacyclin (PGI2) ELISA kits market in 2018. This segment is also projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030. Based on application, laboratories accounted for the largest share of the global prostacyclin (PGI2) ELISA kit market in 2017 and this trend is expected to continue duringthe forecast period from2018to2030 .
 ELISA Kits Industry Outlook.svg)
Product Definition:
A Prostacyclin (PGI2) ELISA kit is a test used to measure the amount of prostacyclin in a sample. Prostacyclin is a hormone that helps keep blood vessels open and improves blood flow. It is important for heart health and may help protect against heart attack and stroke.
Serum:
Prostacyclin (PGI2) is a type of prostaglandin. Prostacyclins are known to have anti-inflammatory, antithrombotic, and analgesic activities. They are produced by the body as well as by some plants and animals. The main function of prostacyclin is to reduce platelet aggregation which helps in preventing thrombus formation hence preventing heart attack or stroke occurrence.
Plasma:
Plasma is the liquid part of blood cells, which carries proteins and other important molecules. It plays an important role in disease diagnosis as it helps detect diseases by binding with specific antibodies. In ELISA (enzyme-linked immunosorbent assay), plasma is used to measure the amount of a particular protein in blood samples.
The usage of plasma for measuring PGI2 levels has been studied extensively.
Application Insights:
Laboratories were the largest application segment and accounted for a revenue share of more than 70% in 2017. Prostacyclin is an important compound that plays a vital role in maintaining cardiovascular system health. Thus, its levels are measured in various laboratories to identify any abnormalities related to cardiovascular system functioning.
The product finds applications not only as a diagnostic tool but also for monitoring the success of treatment procedures, thus boosting its demand from clinical research settings as well as hospitals and laboratories worldwide. The presence of numerous applications has positively influenced the market growth over recent years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a well-established healthcare infrastructure and high adoption of advanced technologies. Moreover, rising prevalence of cardiovascular diseases and respiratory disorders is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to increasing per capita income, growing medical tourism industry, improving healthcare facilities & infrastructure as well as rising awareness about early diagnosis in emerging economies such as China & India. In addition, government initiatives for controlling diabetes are also expected favorably impact regional demand during the same period.
Growth Factors:
- Increasing incidence of cardiovascular diseases: The increasing incidence of cardiovascular diseases is one of the key growth drivers for the Prostacyclin(PGI2) ELISA Kits market. According to a study by the World Health Organization, an estimated 17.5 million people died from CVDs in 2012, accounting for 31% of all global deaths. This number is projected to rise to 23 million by 2030. This growing prevalence of CVDs is expected to drive demand for Prostacyclin(PGI2) ELISA Kits over the forecast period.
- Rising awareness about early diagnosis and treatment: There is a growing awareness among people about the importance of early diagnosis and treatment for various diseases, including CVDs. This is expected to drive demand for Prostacyclin(PGI2) ELISA Kits over the forecast period as they help in early detection and diagnosis of CVDs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prostacyclin(PGI2) ELISA Kits Market Research Report
By Type
Serum, Plasma, Other Biological Fluid
By Application
Laboratories, Hospitals
By Companies
Abcam, Fitzgerald Industries International, Abnova, Biomatik Corporation, Aspira Scientific, United States Biological, Abbexa Ltd, Enzo Life Sciences, Abcam
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
176
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Prostacyclin(PGI2) ELISA Kits Market Report Segments:
The global Prostacyclin(PGI2) ELISA Kits market is segmented on the basis of:
Types
Serum, Plasma, Other Biological Fluid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratories, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- Fitzgerald Industries International
- Abnova
- Biomatik Corporation
- Aspira Scientific
- United States Biological
- Abbexa Ltd
- Enzo Life Sciences
- Abcam
 ELISA Kits Market Overview.svg)
Highlights of The Prostacyclin(PGI2) ELISA Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Serum
- Plasma
- Other Biological Fluid
- By Application:
- Laboratories
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prostacyclin(PGI2) ELISA Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 ELISA Kits Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prostacyclin ELISA Kits are a type of blood test that measure the levels of prostacyclin in your blood. Prostacyclin is a hormone that helps to protect the heart and other organs from damage.
Some of the major players in the prostacyclin(pgi2) elisa kits market are Abcam, Fitzgerald Industries International, Abnova, Biomatik Corporation, Aspira Scientific, United States Biological, Abbexa Ltd, Enzo Life Sciences, Abcam.
The prostacyclin(pgi2) elisa kits market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prostacyclin(PGI2) ELISA Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prostacyclin(PGI2) ELISA Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prostacyclin(PGI2) ELISA Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prostacyclin(PGI2) ELISA Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prostacyclin(PGI2) ELISA Kits Market Size & Forecast, 2018-2028
4.5.1 Prostacyclin(PGI2) ELISA Kits Market Size and Y-o-Y Growth
4.5.2 Prostacyclin(PGI2) ELISA Kits Market Absolute $ Opportunity
Chapter 5 Global Prostacyclin(PGI2) ELISA Kits Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Type
5.2.1 Serum
5.2.2 Plasma
5.2.3 Other Biological Fluid
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Prostacyclin(PGI2) ELISA Kits Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Applications
6.2.1 Laboratories
6.2.2 Hospitals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prostacyclin(PGI2) ELISA Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Prostacyclin(PGI2) ELISA Kits Analysis and Forecast
9.1 Introduction
9.2 North America Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Type
9.6.1 Serum
9.6.2 Plasma
9.6.3 Other Biological Fluid
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Applications
9.10.1 Laboratories
9.10.2 Hospitals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Prostacyclin(PGI2) ELISA Kits Analysis and Forecast
10.1 Introduction
10.2 Europe Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Type
10.6.1 Serum
10.6.2 Plasma
10.6.3 Other Biological Fluid
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Applications
10.10.1 Laboratories
10.10.2 Hospitals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Prostacyclin(PGI2) ELISA Kits Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Type
11.6.1 Serum
11.6.2 Plasma
11.6.3 Other Biological Fluid
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Applications
11.10.1 Laboratories
11.10.2 Hospitals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Prostacyclin(PGI2) ELISA Kits Analysis and Forecast
12.1 Introduction
12.2 Latin America Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Type
12.6.1 Serum
12.6.2 Plasma
12.6.3 Other Biological Fluid
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Applications
12.10.1 Laboratories
12.10.2 Hospitals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Prostacyclin(PGI2) ELISA Kits Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Type
13.6.1 Serum
13.6.2 Plasma
13.6.3 Other Biological Fluid
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Prostacyclin(PGI2) ELISA Kits Market Size Forecast by Applications
13.10.1 Laboratories
13.10.2 Hospitals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prostacyclin(PGI2) ELISA Kits Market: Competitive Dashboard
14.2 Global Prostacyclin(PGI2) ELISA Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam
14.3.2 Fitzgerald Industries International
14.3.3 Abnova
14.3.4 Biomatik Corporation
14.3.5 Aspira Scientific
14.3.6 United States Biological
14.3.7 Abbexa Ltd
14.3.8 Enzo Life Sciences
14.3.9 Abcam
